13F filer · CIK 1103804 ↗
Viking Global
You are looking at Q4 2022. See the latest, Q2 2026 →
Reported value
$19.98B
−7.8% on the quarter before
Positions
76
14 new · 26 sold out
Top 10
41.6%
of the value
Est. gain
+$1.39B
on stocks held all quarter
Est. return
+9.6%
on those stocks since Q3 2022
Positions as of Dec 31, 2022, from Viking Global's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q3 2022. Striped tiles are options.
Largest buys
Since Q3 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Unitedhealth Group Inc~$487.3MAdded · 0.8% → 3.4%+919,153 shares
- Csx Corp~$481.7MNew · 0.0% → 2.4%+15,548,123 shares
- Fortinet~$348.4MNew · 0.0% → 1.7%+7,126,827 shares
- Seagate Technology Hldngs Pl~$326.1MNew · 0.0% → 1.6%+6,198,933 shares
- Amazon~$268.4MAdded · 4.8% → 5.2%+3,195,002 shares
- Brookfield Corp~$228.5MNew · 0.0% → 1.1%+7,262,078 shares
- Li Auto Inc~$185.4MNew · 0.0% → 0.9%+9,090,065 shares
- American Intl Group Inc~$163.8MNew · 0.0% → 0.8%+2,590,026 shares
- Equitable Hldgs Inc~$149.6MNew · 0.0% → 0.7%+5,212,460 shares
- Micron~$147.2MAdded · 1.3% → 2.1%+2,944,793 shares
Largest sells
Since Q3 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Brookfield Asset Mgmt Inc~$603.4MSold out · 2.8% → 0.0%−14,757,027 shares
- Dollar Gen Corp New~$520.9MCut · 2.7% → 0.4%−2,115,520 shares
- T-Mobile Us Inc~$446.1MSold out · 2.1% → 0.0%−3,324,606 shares
- Parker-Hannifin Corp~$430.2MSold out · 2.0% → 0.0%−1,775,453 shares
- General Electric Co~$427.2MCut · 3.7% → 3.3%−5,098,967 shares
- Meta~$356.7MCut · 3.4% → 1.4%−2,963,769 shares
- Salesforce~$345.3MSold out · 1.6% → 0.0%−2,400,649 shares
- International Flavors&Fragra~$344.6MCut · 1.6% → 0.2%−3,287,376 shares
- Boston Scientific Corp~$307.0MCut · 2.9% → 2.2%−6,634,328 shares
- Take-Two Interactive Softwar~$305.7MSold out · 1.4% → 0.0%−2,804,400 shares
Holdings
As of Dec 31, 2022. Changes are in shares against Sep 30, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Visa Inc.COM CL A · shares +8.2% · price +16.9% | 6.0% | $1.20B | +$161.0M | ||||||||
| AmazonCOM · shares +34% · price −25.7% | 5.2% | $1.05B | −$269.3M | ||||||||
| Elevance Health IncCOM · shares −20% · price +12.9% | 4.8% | $960.4M | +$110.0M | ||||||||
| Mckesson CorpCOM · shares −15% · price +10.4% | 4.1% | $826.9M | +$77.7M | ||||||||
| MicrosoftCOM · shares −2.3% · price +3.0% | 4.1% | $822.4M | +$23.7M | ||||||||
| Chubb LimitedCOM · shares −0.4% · price +21.3% | 4.0% | $789.8M | +$138.6M | ||||||||
| Roivant Sciences LtdSHS · shares 0% · price +148.1% | 3.5% | $705.0M | +$420.9M | ||||||||
| Unitedhealth Group IncCOM · shares +264% · price +5.0% | 3.4% | $672.1M | +$8.8M | ||||||||
| General Electric CoCOM NEW · shares −40% · price +35.3% | 3.3% | $651.5M | +$170.1M | ||||||||
| Api Group CorpCOM STK · shares 0% · price +41.7% | 3.2% | $636.1M | +$187.4M | ||||||||
| MastercardCL A · shares −3.5% · price +22.3% | 3.0% | $594.3M | +$108.3M | ||||||||
| Hdfc Bank LtdSPONSORED ADS · shares −12% · price +17.1% | 2.9% | $586.3M | +$85.6M | ||||||||
| Biomarin Pharmaceutical IncCOM · shares +3.4% · price +22.1% | 2.7% | $545.8M | +$95.5M | ||||||||
| Ameriprise Finl IncCOM · shares −8.7% · price +23.6% | 2.6% | $513.1M | +$97.9M | ||||||||
| Csx CorpCOM · shares New | 2.4% | $481.7M | — | ||||||||
| Thermo Fisher Scientific IncCOM · shares +41% · price +8.6% | 2.3% | $462.3M | +$25.8M | ||||||||
| IntuitCOM · shares +2.1% · price +0.5% | 2.3% | $459.9M | +$2.2M | ||||||||
| Boston Scientific CorpCOM · shares −41% · price +19.5% | 2.2% | $440.9M | +$71.8M | ||||||||
| MicronCOM · shares +54% · price −0.2% | 2.1% | $417.8M | −$649,528 | ||||||||
| Royalty Pharma PlcSHS CLASS A · shares −8.0% · price −1.6% | 2.0% | $395.5M | −$6.6M | ||||||||
| FortinetCOM · shares New | 1.7% | $348.4M | — | ||||||||
| Seagate Technology Hldngs PlORD SHS · shares New | 1.6% | $326.1M | — | ||||||||
| MetaCL A · shares −55% · price −11.3% | 1.4% | $287.3M | −$36.6M | ||||||||
| BlockCL A · shares −16% · price +14.3% | 1.4% | $281.8M | +$35.2M | ||||||||
| Acadia Healthcare Company InCOM · shares +6.8% · price +5.3% | 1.3% | $260.2M | +$12.3M | ||||||||
| Total · 76 positions | 100% | $19.98B | +$1.39B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2022 to Q4 2022: 61 stocks held throughout, up $1.39B (+9.6%).
- Roivant Sciences Ltd+$420.9M+148%
- Api Group Corp+$187.4M+42%
- General Electric Co+$170.1M+35%
- Visa Inc.+$161.0M+17%
- Chubb Limited+$138.6M+21%
- Intellia Therapeutics Inc−$39.8M−38%
- Bridgebio Pharma Inc−$61.8M−23%
- Ginkgo Bioworks Holdings Inc−$90.2M−46%
- Guardant Health Inc−$102.1M−49%
- Amazon−$269.3M−26%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $35.08B−2% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $35.75B−5% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $37.68B−2% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $38.50B+11% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $34.59B+10% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $31.48B+2% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $30.90B+13% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $27.44B+5% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $26.02B−3% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $26.86B−2% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $27.30B+11% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $24.64B+1% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $24.43B+15% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $21.31B+7% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $19.98B−8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $21.66B−1% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $21.86B−12% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $24.74B−29% | SEC ↗ |
| Q4 2021 | May 16, 2022 (amended) | $34.71B−5% | SEC ↗ |
| Q3 2021 | May 16, 2022 (amended) | $36.46B+11% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $32.98B−2% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $33.58B−8% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $36.37B+31% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $27.68B+20% | SEC ↗ |
| Q2 2020 | Aug 7, 2020 | $23.14B+20% | SEC ↗ |
| Q1 2020 | May 13, 2020 | $19.21B−10% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $21.35B+11% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $19.20B−14% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $22.29B+28% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $17.44B−1% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $17.57B−3% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $18.06B+3% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $17.47B+5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $16.61B+2% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $16.26B+5% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $15.44B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $14.85B−34% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $22.64B+3% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $22.01B−5% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $23.18B−2% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $23.54B+4% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $22.72B | SEC ↗ |